openPR Logo
Press release

Living cells as an "active drug" Advances in image-guided cell therapy promise breakthrough in the treatment of cancer and diabetes ENCITE Video launch

11-29-2012 07:55 PM CET | Health & Medicine

Press release from: EIBIR GmbH

ENCITE Video

ENCITE Video

Leiden, Austria, November 19, 2012 - A video showcasing how in vivo image-guided cell therapy is revolutionising medicine and describing ENCITE’s strong contribution to this revolution has been launched at the ENCITE’s workshop “on cell imaging and tracking: now and the future” at the Leiden University Medical Centre/NL on November 5, 2012.
For three patients, each affected by one of today’s major health care problems – diabetes, cancer and cardiovascular disease – cell therapy represents a promising treatment. Transplanted living cells act as an “active drug” by producing hormones, destroying tumour cells or regenerating damaged tissues. However, there is a major hurdle to be overcome before these novel cell therapies can be made available to patients… The mechanisms underlying how cell therapy works are poorly understood. To watch the video, please visit the ENCITE website (www.encite.org) and/or download the file here.
ENCITE has made a real impact on the treatment of healthcare problems that affect our every day lives. To better understand how cell therapy works, prominent researchers have been working together to develop imaging tools for novel cellular therapies. The ENCITE scientists have joined forces to translate important research developments into clinical practice…Helping to make cellular therapy a reality, not just a future dream.
Details on the latest news: www.encite.org
Contact:
European Institute for Biomedical Imaging Research (EIBIR), Project Coordination
Neutorgasse 9, 1010 Vienna (AT)
Phone: +43-1-5334064-20 / office@eibir.org / www.eibir.org, www.encite.org
Scientific Coordinator: Prof. Gabriel P. Krestin, ERASMUS MC, ehaas@eibir.org
###

EIBIR - European Institute for Biomedical Imaging Research
Website: www.eibir.org
Contact: office@eibir.org

EIBIR gemeinnützige GmbH
zur Förderung der Erforschung der biomedizinischen Bildgebung
Neutorgasse 9, 1010 Vienna, Austria
T +43 1 533 40 64-20, F +43 1 535 70 41
www.eibir.org

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Living cells as an "active drug" Advances in image-guided cell therapy promise breakthrough in the treatment of cancer and diabetes ENCITE Video launch here

News-ID: 244243 • Views:

More Releases from EIBIR GmbH

ENCITE Symposium”Red hot MRI: In vivo 19F imaging” Towards clinical application
ENCITE Symposium ”Red hot MRI: In vivo 19F imaging” Towards clinical applic …
Nijmegen, The Netherlands, October 29, 2012: The European Network for Cell Imaging and Tracking Expertise (ENCITE) held a 2-day symposium at the Radboud University Nijmegen Medical Centre (NL) on October 25-26, 2012 on the emerging technique of fluorine (19F) Magnetic Resonance Imaging (MRI), titled "Red hot MRI: In vivo 19F imaging". 19F MRI is uniquely applicable to areas such as cell tracking. This has yet to be applied in the
ENCITE hands-on workshop “Cell tracking with MRI“ The method of choice for preclinical investigations of revealing cell dynamics in vivo
ENCITE hands-on workshop “Cell tracking with MRI“ The method of choice for p …
Cologne, Germany, November 14, 2012: Within the framework of the European Network for Cell Imaging and Tracking Expertise (ENCITE) the In-vivo-NMR laboratory at the Max-Planck-Institute for Neurological Research (DE) invited to a 3-day hands-on workshop on November 7-9, 2012, kindly supported by the companies Miltenyi Biotec, Viscover and Medres. The workshop was dedicated to elucidate the techniques and methods necessary for MRI based cell tracking with a focus on neuroimaging.
Cell imaging and tracking: now and the future Promising methods developed to play a central role in tomorrow’s medicine
Cell imaging and tracking: now and the future Promising methods developed to pla …
Vienna, Austria, November 12, 2012 – The European Network for Cell Imaging and Tracking Expertise (ENCITE) held its final workshop on cell imaging and tracking at the Leiden University Medical Centre/NL, on November 5, 2012, attracting over 100 participants. In addressing the questions “What are the clinical needs for imaging and improved disease diagnosis?” and “What are the best tools for translation to clinic?” ENCITE has achieved promising advances, some

All 4 Releases


More Releases for ENCITE

Dermatology Software Market Company Insights & SWOT Analysis by 2027 | Henry Sch …
Vital fundamentals greatly help key players in making business related decision by overcoming the challenges and this Dermatology Software market report aims at providing these fundamentals. This market research report is formed using latest market intelligence tools. It further heads towards capturing detailed observation of a number of customer journeys that greatly affect the market sectors. Client viewpoints can be attained here about services as well as goods. This Dermatology
Dermatology Software Market Will Hit Big Revenues In Future | Remedly, Kareo, Ne …
Global Dermatology Software Market Report from AMA Research highlights deep analysis on market characteristics, sizing, estimates and growth by segmentation, regional breakdowns& country along with competitive landscape, player’s market shares, and strategies that are key in the market. The exploration provides a 360° view and insights, highlighting major outcomes of the industry. These insights help the business decision-makers to formulate better business plans and make informed decisions to improved profitability.
ENCITE Symposium ”Red hot MRI: In vivo 19F imaging” Towards clinical applic …
Nijmegen, The Netherlands, October 29, 2012: The European Network for Cell Imaging and Tracking Expertise (ENCITE) held a 2-day symposium at the Radboud University Nijmegen Medical Centre (NL) on October 25-26, 2012 on the emerging technique of fluorine (19F) Magnetic Resonance Imaging (MRI), titled "Red hot MRI: In vivo 19F imaging". 19F MRI is uniquely applicable to areas such as cell tracking. This has yet to be applied in the
ENCITE Final Public Workshop
The European Network for Cell Imaging and Tracking Expertise invites you to the final public event. Monday, 5 November 2012, 8:00 – 18:00 Leiden University Medical Center, Leiden/NL Programme available at: www.encite.org No registration fee required! For pre-registration, please send an email to: All involved scientists in ENCITE are very pleased to announce that the end of the highly successful ENCITE project will be marked by a closing event presenting new technologies and methods
ENCITE Workshop on Molecular Imaging in Skeletal Tissue Regeneration
Date: 25—27 October 2011 Venue: Tel Aviv University/IL Students and scientists involved in biomedical imaging, tissue regeneration and stem cell therapies with focus on skeletal disorders are welcome. Both ENCITE partners, the Tel Aviv University and the Hebrew University of Jerusalem, are pleased to organise this workshop. Further information on other ENCITE events can be found online at http://www.encite.org/cms/website.php?id=/en/index/training_platform/encite_trainings/2011.htm&scroll=scrollpage_text12775 ENCITE project www.encite.org/cms/website.php The European Institute for Biomedical Imaging Research (EIBIR) was established by the European Society
ENCITE Mini-categorical Course on Molecular Imaging at ESMRMB 2011
Date: 6—8 October 2011, 08:00–09:00 Venue: Leipzig/DE Meet ENCITE experts at ESMRMB 2011! New tools, MR contrast agents and sequences as well as in vivo / in vitro spectroscopy work and cell tracking in a pre-clinical setting will be presented. Experts from the Netherlands, the United Kingdom, Germany and Belgium will present new tools for optical imaging, MR contrast agents and MR sequences as well as news on in vitro and in vivo spectroscopy,